Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

Journal of Clinical Microbiology

Volumn 45, Issue 4, 2007, Pages 1167-1174

  Wiegand, Irith ^a   Geiss, Heinrich K ^b   Mack, Dietrich ^c   Stürenburg, Enno ^d   Seifert, Harald ^e  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WALES   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE KOXY; BETA LACTAMASE SHV; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CITROBACTER FREUNDII; DIAGNOSTIC VALUE; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENZYME ASSAY; ESCHERICHIA COLI; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LABORATORY AUTOMATION; MICROBIOLOGICAL EXAMINATION; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CITROBACTER FREUNDII; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; MORGANELLA MORGANII; PREDICTIVE VALUE OF TESTS; PROTEUS; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS;

CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; PROTEUS MIRABILIS; PROTEUS VULGARIS; SERRATIA MARCESCENS;

EID: 34247278269     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01988-06     Document Type: Article

References (29)

1. Andes, D., and W. A. Craig. 2005. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. Clin. Microbiol. Infect. 11(Suppl. 6):10-17.
2. Bonnet, R., C. Recule, R. Baraduc, C. Chanal, D. Sirot, C. De Champs, and J. Sirot. 2003. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52:29-35.
3. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16. CLSI, Wayne, Pa.
4. De Gheldre, Y., V. Avesani, C. Berhin, M. Delmee, and Y. Glupczynski. 2003. Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 52:591-597.
5. Jacoby, G. A., and L. Sutton. 1991. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 35:164-169.
6. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
7. Kliebe, C., B. A. Nies, J. F. Meyer, R. M. Tolxdorff-Neutzling, and B. Wiede mann. 1985. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28:302-307.
8. Koeck, J. L., G. Arlet, A. Philippon, S. Basmaciogullari, H. V. Thien, Y. Buisson, and J. D. Cavallo. 1997. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152:255-260.
9. Komatsu, M., M. Aihara, K. Shimakawa, M. Iwasaki, Y. Nagasaka, S. Fukuda, S. Matsuo, and Y. Iwatani. 2003. Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan. Diagn. Microbiol. Infect. Dis. 46:125-130.
10. Leverstein-van Hall, M. A., A. C. Fluit, A. Paauw, A. T. Box, S. Brisse, and J. Verhoef. 2002. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 40:3703-3711.
11. Linscott, A. J., and W. J. Brown. 2005. Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests. J. Clin. Microbiol. 43:1081-1085.
12. Livermore, D. M., and D. F. Brown. 2001. Detection of beta-lactamase-mediated resistance. J. Antimicrob. Chemother. 48(Suppl. 1):59-64.
13. Livermore, D. M., and N. Woodford. 2006. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas, and Acinetobacter. Trends Microbiol. 14:413-420.
14. M'Zali, F. H., A. Chanawong, K. G. Kerr, D. Birkenhead, and P. M. Hawkey. 2000. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. J. Antimicrob. Chemother. 45:881-885.
15. Nuesch-Inderbinen, M. T., H. Hachler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402.
16. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
17. Peter, K., G. Korfmann, and B. Wiedemann. 1988. Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. Rev. Infect. Dis. 10:800-805.
18. Pitout, J. D., P. Nordmann, K. B. Laupland, and L. Poirel. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59.
19. Potz, N. A., M. Colman, M. Warner, R. Reynolds, and D. M. Livermore. 2004. False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase. J. Antimicrob. Chemother. 53:545-547.
20. Sanguinetti, M., B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.
21. Schiefer, A. M., I. Wiegand, K. J. Sherwood, B. Wiedemann, and I. Stock. 2005. Biochemical and genetic characterization of the beta-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and "Y. ruckeri" strains. Int. J. Antimicrob. Agents 25:496-500.
22. Schwaber, M. J., S. Navon-Venezia, I. Chmelnitsky, A. Leavitt, D. Schwartz, and Y. Carmeli. 2006. Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. J. Clin. Microbiol. 44:241-243.
23. Stürenburg, E., M. Lang, M. A. Horstkotte, R. Laufs, and D. Mack. 2004. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant gram-negative bacteria. J. Antimicrob. Chemother. 54:870-875.
24. Stürenburg, E., I. Sobottka, D. Noor, R. Laufs, and D. Mack. 2004. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J. Antimicrob. Chemother. 54:134-138.
25. Stürenburg, E., and D. Mack. 2003. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J. Infect. 47:273-295.
26. Stürenburg, E., I. Sobottka, H. H. Feucht, D. Mack, and R. Laufs. 2003. Comparison of BD Phoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn. Microbiol. Infect. Dis. 45:29-34.
27. Thomson, K. S., and E. S. Moland. 2001. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 45:3548-3554.
28. Vercauteren, E., P. Descheemaeker, M. Ieven, C. C. Sanders, and H. Goos sens. 1997. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol. 35:2191-2197.
29. Woodford, N., E. J. Fagan, and M. J. Ellington. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57:154-155.